RUA Life Sciences plc (AIM:RUA)

London · Delayed Price · Currency is GBP · Price in GBX

24.55

+0.55 (2.29%)

Jul 27, 2026, 2:10 PM GMT

RUA Life Sciences Financials Overview

Financials in millions GBP. Fiscal year is October - September.

Millions GBP. Fiscal year is Oct - Sep.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Revenue	4.62	4.46	4.11	2.19	2.18	1.63
Revenue Growth	3.54%	8.42%	87.72%	0.55%	34.09%	6.35%
Gross Profit	3.61	3.46	3.17	1.72	1.73	1.27
Operating Income	0.14	-0.17	-0.02	-1.94	-2.31	-2.35
Net Income	0.28	-0.15	0	-1.44	-2	-2.07
Earnings Per Share	0.00	-0.00	0.00	-0.04	-0.09	-0.09
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Fiscal Year	TTM	FY 2025	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Biomaterials	0.75	0.61	0.59	0.5	0.55	0.49
Vascular	-	0.01	-	0.02	-	-
Contract Manufacturing	-	3.84	3.53	1.68	1.63	1.14
Total	4.62	4.46	4.11	2.19	2.18	1.63

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Investments	2.37	3.25	3.57	3.93	1.48	2.96
Total Debt	0.65	0.79	1.03	0.39	0.48	0.34
Net Cash (Debt)	1.71	2.46	2.54	3.54	1.01	2.62
Net Cash Growth	-30.21%	-3.23%	-28.35%	251.04%	-61.47%	-55.49%
Net Cash Per Share	0.03	0.04	0.04	0.11	0.05	0.12

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Cash Flow	-0.9	-0.13	-0.22	-1.33	-1.15	-2.35
Capital Expenditures	-0.12	-0.11	-0.06	-0.06	-0.45	-0.9
Free Cash Flow	-1.02	-0.24	-0.28	-1.38	-1.6	-3.26
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Gross Margin	78.20%	77.50%	77.12%	78.32%	79.30%	78.22%
Operating Margin	2.94%	-3.84%	-0.49%	-88.41%	-105.83%	-144.74%
Pretax Margin	6.51%	-3.53%	-0.24%	-92.20%	-106.56%	-145.23%
Profit Margin	6.10%	-3.26%	0.02%	-65.72%	-91.92%	-127.20%
FCF Margin	-22.11%	-5.29%	-6.83%	-63.12%	-73.20%	-200.43%

Valuation

Fiscal Year	Current	FY 2025	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul '26 Jul 28, 2026	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
PE Ratio	53.99	-	7447.23	-	-	-
PS Ratio	3.29	1.57	1.81	2.55	5.24	6.69